Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids in Bipolar Disorder Prophylaxis
NCT00010868Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3 fatty acid in bipolar disorder (BD), sponsored by National Center for Complementary and Integrative Health. Started Jul 2000; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00010868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010868.